Company looks good and seems to leading the pack. Anti thesis
Company is expesive even after 30 percent correction.
Highly competitive segment
High Esop issuance.
Low margin as of now
Only thing in favour is Management is growth focused and has a buge addressable market.
Interested
| Subscribe To Our Free Newsletter |
